In newly released lab results from one of the nation’s largest labs with a presence in over 30 countries, both Usana and Herbalife have lead levels that are over 1000 times the lead allowed under California law when taken as directed daily. The new results also revealed that the average lead content for non multi level marketing health drinks averaged 0.607 micrograms per day while Usana and Herbalife combined for a whopping 9.760 micrograms of lead per day. %26quot;I do not care what your liberal interpretation of Proposition 65 might be,%26quot; said attorney Christopher Grell, %26quot;but these percentages are astounding and will hopefully catch the eye of California regulators.%26quot;
Also released today was the results of a 10 year study conducted by multi level marketing expert Robert Fitzpatrick where he analyzed 11 multi level marketing company’s, five of which are publicly traded.
In that study,
Mr. Fitzpatrick reveals the truth regarding the myth of the multi level marketing business opportunity by uncovering three undeniable truths: on average no net income is earned by MLM distributors from door to door "retail" sales the sales forces of Herbalife, Usana and the other company’s analyzed are churned (lost money/quit/replaced) at rates between 60-90% each year and 99% of all sales representatives each year in the sample of companies analyzed earned on average less than $13 a week in commission income.
According to Mr. Fitzpatrick in the report prepared for Mr. Grell, "The (income) figure represents a significant financial loss for virtually all that join these schemes. As extreme as the loss rate is, this figure is conservatively understated because it is calculated before all business expenses, inventory purchases and taxes are factored, which would increase total losses and the percentage of those losing."
Tuesday, December 28, 2010
Friday, December 24, 2010
Researchers Seek Participants For Antibiotic Use Study
Researchers conducting a study to learn if children with a urinary tract disorder known as vesicoureteral reflux (VUR) should be treated with an antibiotic for an extended period of time are seeking to enroll more participants. The study, known as the Randomized Intervention for Children with Vesicoureteral Reflux (RIVUR) study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), one of the National Institutes of Health (NIH).
VUR is the abnormal flow of urine from the bladder back up into the tubes that run to the kidneys. These tubes are called ureters. Normally, urine flows down the ureters to the bladder. VUR is the most common functional abnormality of the urinary tract in children. It is found in 30 percent to 50 percent of children with urinary tract infections (UTIs) and is thought to increase the risk of kidney damage when children have recurring UTIs. At least 30 percent of children who have at least one UTI will have a recurrence.
Scar tissue in the kidney, called renal scarring, occurs between 5 percent and 40 percent of the time when a child has a UTI. Scarring may build up with each infection and can lead to progressive kidney failure and the need for renal-replacement therapy, such as dialysis.
About 50 years ago physicians began to prescribe an ongoing regimen of daily antibiotics for children with VUR, based on the belief that treatment would prevent infections and reduce scarring and kidney failure. Unfortunately, the number of children developing kidney failure from VUR has not changed in that time, leading physicians to question the value of the practice and adding to concerns about increasing antibiotic resistance in the general population.
"The RIVUR study has the potential to help us understand how to provide the best care for tens of thousands of children diagnosed every year with this condition,"said Marva Moxey-Mims, M.D., director of NIDDK’s pediatric nephrology program in the Division of Kidney, Urologic, and Hematologic Diseases. "In addition to finding out if antibiotics reduce the risk of UTIs, we also need to understand the progression of renal scarring and the development of resistance to antibiotics in these children."
The researchers seek to enroll 600 participants. So far, 125 infants and children have joined the study. Participants must be between the ages of 2 months and 6 years and have had their first or second UTI within 10 weeks or 112 days of study enrollment. With the approval of 20 institutional review boards and an external data safety monitoring board charged with overseeing the safety of children in the trial, each participant receives a daily dose of an antibiotic or a placebo for up to two years. Children who develop recurring fever or other symptoms of infection or scar tissue buildup in the kidney will be switched from the study to routine antibiotic care and referred to a urologist, depending on the number of infections and degree of renal scarring.
VUR is the abnormal flow of urine from the bladder back up into the tubes that run to the kidneys. These tubes are called ureters. Normally, urine flows down the ureters to the bladder. VUR is the most common functional abnormality of the urinary tract in children. It is found in 30 percent to 50 percent of children with urinary tract infections (UTIs) and is thought to increase the risk of kidney damage when children have recurring UTIs. At least 30 percent of children who have at least one UTI will have a recurrence.
Scar tissue in the kidney, called renal scarring, occurs between 5 percent and 40 percent of the time when a child has a UTI. Scarring may build up with each infection and can lead to progressive kidney failure and the need for renal-replacement therapy, such as dialysis.
About 50 years ago physicians began to prescribe an ongoing regimen of daily antibiotics for children with VUR, based on the belief that treatment would prevent infections and reduce scarring and kidney failure. Unfortunately, the number of children developing kidney failure from VUR has not changed in that time, leading physicians to question the value of the practice and adding to concerns about increasing antibiotic resistance in the general population.
"The RIVUR study has the potential to help us understand how to provide the best care for tens of thousands of children diagnosed every year with this condition,"said Marva Moxey-Mims, M.D., director of NIDDK’s pediatric nephrology program in the Division of Kidney, Urologic, and Hematologic Diseases. "In addition to finding out if antibiotics reduce the risk of UTIs, we also need to understand the progression of renal scarring and the development of resistance to antibiotics in these children."
The researchers seek to enroll 600 participants. So far, 125 infants and children have joined the study. Participants must be between the ages of 2 months and 6 years and have had their first or second UTI within 10 weeks or 112 days of study enrollment. With the approval of 20 institutional review boards and an external data safety monitoring board charged with overseeing the safety of children in the trial, each participant receives a daily dose of an antibiotic or a placebo for up to two years. Children who develop recurring fever or other symptoms of infection or scar tissue buildup in the kidney will be switched from the study to routine antibiotic care and referred to a urologist, depending on the number of infections and degree of renal scarring.
Wednesday, December 22, 2010
Jobs and Schwarzeneggar Team Up for Organ Donation
Apple CEO Steve Jobs, 55, had a liver transplant rescue last year. Yesterday he appeared unexpectedly at the hospital at Stanford Lucile Packard Children tell their story transplantation.
Mercury News reports Jobs said: "I was almost one of those who died waiting for a liver in California last year."
Jobs joined Governor Arnold Schwarzenegger in an effort to push the new California law that would expand the number of donor organ California.
Procurement and transplantation Network (OPTN), and this morning there are 106 627 in the United States awaiting organ transplants. The number of people who are in need of donor organs continues to grow. There are currently more than 21,000 Californians waiting donor organs.
Last year, Florida has launched a new website, www.DonateLifeFlorida.org, to make it easier for Florida to become organ donors. The new legislation is sponsored by California State Senator Elaine Alquist, D-San Jose would require applicants for driver's licenses to answer whether they will be organ and tissue donor before the Department of Motor Vehicles shall issue their license. Those wishing to donate will be added to the state registry.
Currently, DMV issues a license regardless of whether the applicant answer that question. It is reported that of 26 million drivers in California, only 6.3 million have signed an organ and tissue donors.
The bill also creates a "California Living Donor Registry," which connects sick patients altruistic strangers who are willing to donate a kidney.
Commending Jobs, the governor said: "What I like Steve because he is a wealthy man, who helped him get a transplant, but he does not want to -. That only rich people can get a transplant and the plane waiting to take him anywhere, he needs to go. He wants every man, if you have no money at all, or if you're a rich man in the world. Everyone should have the right to receive transplants at once. "
Mercury News reports Jobs said: "I was almost one of those who died waiting for a liver in California last year."
Jobs joined Governor Arnold Schwarzenegger in an effort to push the new California law that would expand the number of donor organ California.
Procurement and transplantation Network (OPTN), and this morning there are 106 627 in the United States awaiting organ transplants. The number of people who are in need of donor organs continues to grow. There are currently more than 21,000 Californians waiting donor organs.
Last year, Florida has launched a new website, www.DonateLifeFlorida.org, to make it easier for Florida to become organ donors. The new legislation is sponsored by California State Senator Elaine Alquist, D-San Jose would require applicants for driver's licenses to answer whether they will be organ and tissue donor before the Department of Motor Vehicles shall issue their license. Those wishing to donate will be added to the state registry.
Currently, DMV issues a license regardless of whether the applicant answer that question. It is reported that of 26 million drivers in California, only 6.3 million have signed an organ and tissue donors.
The bill also creates a "California Living Donor Registry," which connects sick patients altruistic strangers who are willing to donate a kidney.
Commending Jobs, the governor said: "What I like Steve because he is a wealthy man, who helped him get a transplant, but he does not want to -. That only rich people can get a transplant and the plane waiting to take him anywhere, he needs to go. He wants every man, if you have no money at all, or if you're a rich man in the world. Everyone should have the right to receive transplants at once. "
Subscribe to:
Posts (Atom)